PMID: 9194754Jun 1, 1997Paper

Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity

Arteriosclerosis, Thrombosis, and Vascular Biology
K HiranoY Matsuzawa

Abstract

Low levels of HDL cholesterol have been clearly demonstrated to be associated with an increased incidence of coronary heart disease, strongly suggesting that HDL particles have an antiatherogenic function. However, little information has been available concerning the atherogenicity of a marked hyperalphalipoproteinemia (HALP). There is no agreement about whether plasma cholesteryl ester transfer protein (CETP) deficiency is associated with an antiatherogenic state or not, although this disorder was reported to be one of the major causes of marked HALP. In the current study, we have found a unique area (Omagari City, Akita Prefecture, Japan) where CETP deficiency caused by a G-to-A mutation at the 5' splice donor site of intron 14 in the CETP gene is extremely frequent. In Omagari City, the mutation was detected more than 20 times more frequently and the prevalence of a marked HALP with plasma HDL cholesterol > or = 2.58 mmol/L (100 mg/dL) was 5 to 10 times higher than in other areas of Japan. This discovery has made it possible to perform a large population-based study concerning the atherogenicity of a marked elevation of HDL cholesterol in a genetically more homogeneous population. There was a statistically significant U-shap...Continue Reading

References

Nov 1, 1975·Metabolism: Clinical and Experimental·C J GlueckR C Go
Aug 1, 1991·European Journal of Clinical Investigation·G FranceschiniC R Sirtori
Mar 1, 1990·Age and Ageing·M Nikkilä, J Heikkinen
Nov 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·D Reichl, N E Miller
Oct 1, 1995·Current Opinion in Lipidology·C Bruce, A R Tall

❮ Previous
Next ❯

Citations

Aug 14, 2001·Biochemical and Biophysical Research Communications·K Okumura-NojiS Yokoyama
Sep 21, 2001·Biochemical and Biophysical Research Communications·K TsukamotoY Matsuzawa
Feb 28, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Vassilis I ZannisMonty Krieger
Nov 15, 2007·European Journal of Clinical Pharmacology·Karin HedenmalmGunnar Alvan
Dec 10, 2003·Current Atherosclerosis Reports·Michael H Davidson
Jun 14, 2006·Current Atherosclerosis Reports·Atif Qasim, Daniel J Rader
Apr 18, 2013·Current Atherosclerosis Reports·Julian C van CapelleveenJohn J P Kastelein
Jun 23, 2012·Current Treatment Options in Cardiovascular Medicine·Michael H Davidson
Apr 3, 2012·The American Journal of Cardiology·Weerapan KhovidhunkitWanee Plengpanich
Dec 12, 2003·Metabolism: Clinical and Experimental·Katsunori IkewakiUNKNOWN Japan CETP Study Group
Oct 6, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·T AraiK Matsumoto
Mar 16, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·Y ZhuangG Chen
Jul 10, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Junjun WangYiyi Zhuang
Apr 8, 2003·European Journal of Pharmacology·Hiroshi OkamotoKorekiyo Wakitani
Jul 16, 2003·Atherosclerosis·Michael H DavidsonUna Ryan
Aug 7, 1998·Atherosclerosis·G de BackerM Kornitzer
Jul 17, 1999·Atherosclerosis·O Stein, Y Stein
Oct 27, 1998·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·V Guyard-DangremontL Lagrost
Dec 9, 2000·Biochimica Et Biophysica Acta·S YamashitaY Matsuzawa
Jan 25, 2007·Nature Clinical Practice. Cardiovascular Medicine·Daniel J Rader
Jan 19, 2011·Nature Reviews. Cardiology·Emil M Degoma, Daniel J Rader
Mar 28, 2007·The New England Journal of Medicine·Steven E NissenUNKNOWN ILLUSTRATE Investigators
Nov 29, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Tanya A KoropatnickJ David Curb
Aug 17, 2000·Current Opinion in Lipidology·A InazuH Mabuchi
Nov 22, 2000·Current Opinion in Lipidology·K HiranoY Matsuzawa
Aug 17, 2001·Current Opinion in Lipidology·P J Barter, K A Rye
Jul 10, 2004·Current Opinion in Lipidology·S Matthijs BoekholdtArie van Tol
Mar 16, 2005·Current Opinion in Lipidology·G Kees HovinghJohn J P Kastelein
Aug 28, 2004·BMJ : British Medical Journal·Gilbert R Thompson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.